BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20210101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220919
DTEND;VALUE=DATE:20220924
DTSTAMP:20260516T033510
CREATED:20220317T083147Z
LAST-MODIFIED:20220317T083147Z
UID:33597-1663545600-1663977599@www.pharmajournalist.com
SUMMARY:7th CAR-TCR Summit
DESCRIPTION:Back to Boston with a bang! With 1\,500 CAR and TCR developers\, 200 speakers\, 150 live presentations\, 20 hours of networking and more surprises in store\, the 7th CAR-TCR Summit will be the BIGGEST ever. \nGain end-to-end insights from industry giants and the innovators bringing disruptive technologies from bench to bedside and from vein to vein. \nDiscuss everything from novel allogeneic approaches with enhanced safety considerations\, the latest in vivo gene engineering techniques\, and advances in CMC and analytics to ensure the development of high-quality cell products. \nWith your industry reuniting in-person for the first time since 2019 to discuss leveraging the powerful potential of iPSC platforms\, learnings from our successes and pitfalls\, and manufacturing automation innovations for large scale consistent production\, you can’t afford to miss the 7th Annual CAR-TCR Summit as we bring you more speakers\, more content and more exclusive insights than ever before! \nTo know more visit: https://ter.li/km5zwy
URL:https://www.pharmajournalist.com/event/7th-car-tcr-summit/
LOCATION:Boston\, MA
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220919
DTEND;VALUE=DATE:20220921
DTSTAMP:20260516T033510
CREATED:20220523T112249Z
LAST-MODIFIED:20220523T112249Z
UID:34202-1663545600-1663718399@www.pharmajournalist.com
SUMMARY:2nd Annual Aseptic Processing Conference
DESCRIPTION:2nd Annual Aseptic Processing Conference  \nConference: 19 – 20 September 2022\nWorkshop: 21 September 2022 \nLondon\, UK\nhttp://www.asepticprocessing.co.uk/PJWL \n \nSponsored by: Dec Group\, Rapid Micro Biosystems\, Raumedic and STERIS\n\nConference Chairman: James Drinkwater\, Head of Aseptic Processing Special Interest Group PHSS and Head of GMP Compliance\, F Ziel GMBH \nDriving a Holistic Approach to Assurance of Product Sterility through Aseptic Manufacturing following QRM Principles \nSAE Media Group proudly presents the 2nd Annual Aseptic Processing Conference\, this year taking place in London\, on the 19 and 20 September 2022. \nThe Aseptic processing industry has seen consistent growth in recent years\, with advances in innovative therapeutics\, the introduction of novel techniques and personnel protocols\, the integration of robotics and automation in filling lines\, and rise of rapid microbiological methods being just a few of the factors driving this growth. \nThe Aseptic Processing equipment market was approaching a valuation of 10 billion USD in 2015\, and is projected to exceed 12 billion USD in value by next year\, then to far surpass a total market value of 50 billion USD before the end of the decade. \nJoin us to discuss and address the  Guidance and Regulation including the EU GMP Annex 1\, environmental control delving into the contamination control strategy\, Pharma moving forward 4.0 covering data integrity and data consistency\, robotics in aseptic processing and exploring the continued aseptic processing development in Annex 1 and environmental monitoring \nThis event is CPD Accredited  \nEvent Hashtag: #AsepticProcessing  \nBenefits of Attending: \n\nDiscuss the revisions and the impact of Annex 1 on aseptic manufacturing\nExplore the applications of rapid micro methods in the manufacture of sterile products\nDiscover a risk-based approach to cleaning and disinfection\nDelve into case studies of competence in global aseptic manufacturing\nUncover the journey of isolation technology in a large biotech pharmaceutical plant\nAnalyse the new abilities of robotics and automation through their integration into aseptic technique\n\n Who Should Attend? \n\nValidation Managers\nSenior Microbiologists\nSenior QA’s and QC’s\nQuality Control Managers\nHeads of GMP Compliance\nQuality Assurance Experts\nTechnical Operations Leads\nLeaders in Sterility Assurance\nCleanroom Managers\nRegulatory Affairs Managers\nProduction Managers\nQuality Systems Managers\nHeads of Quality Compliance\nProcess Leaders\nSenior Auditors\nBioprocess Research & Development\n\n PLUS – Post-Conference Workshop on 21 September 2022… \nImplementation Strategy of Annex 1 in New or Existing Facilities \nLed by: Richard Denk\, Senior Consultant Aseptic Processing & Containment\, Skan AG \nView the brochure and to download visit http://www.asepticprocessing.co.uk/PJWL
URL:https://www.pharmajournalist.com/event/2nd-annual-aseptic-processing-conference/
LOCATION:London\, UK
ORGANIZER;CN="SAE Media Group":MAILTO:ssapal@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220919
DTEND;VALUE=DATE:20220921
DTSTAMP:20260516T033510
CREATED:20220524T091925Z
LAST-MODIFIED:20220524T091925Z
UID:34218-1663545600-1663718399@www.pharmajournalist.com
SUMMARY:Pre-Filled Syringes San Francisco
DESCRIPTION:SAE Media Group’s 3rd Annual Conference\nSeptember 19 – 20\, 2022 | San Francisco\, CA\, USA\n————————————————————————- \nThe pre-filled syringes industry is growing at an exponential rate with innovations in parenteral delivery device development to aid self-administration and deliver biologics\, high concentration\, and large-volume drug products. \n \nThis year’s conference will be assessing the latest developments in new technologies for next generation device design\, including computational simulation approaches forming the digital revolution of devices design. Furthermore\, the latest advances in digital combination product development will be explored through the lens of lifecycle management and user-centric combination products. Leading experts from big pharma will be presenting case studies on recent advances in platform approaches in drug delivery devices and smart devices\, while a panel discussion will explore the emerging opportunities of platforms for injectable devices. With recent developments in industry regulations and guidance\, the 2022 agenda will give an international insight into the global regulatory environment and leading FDA representatives will address the key standards to be aware of in injectable device development.  \nOver recent years we have seen the need for injectable devices to adapt to novel therapeutics. Our expert industry thought leaders will present case studies and updates to the industry’s approach to injectable delivery for novel drug products. Furthermore\, our speakers will be assessing the key considerations for primary packaging and CMC approaches to injectable device development.  \nAs part of SAE Media Group’s leading injectable drug delivery portfolio\, this event is not to be missed. \nThe two-day agenda offers you peer-to-peer networking with Global Product Managers\, Senior PFS Engineers\, Device Testing Managers\, Heads of Late-Stage PFS Development and many more. \nTo know more visit: http://www.prefilled-sanfrancisco.com/pharmajournalistwl
URL:https://www.pharmajournalist.com/event/pre-filled-syringes-san-francisco-2022/
LOCATION:Hyatt Centric\, Fisherman’s Wharf\, San Francisco\, CA\, 94133\, United States
ORGANIZER;CN="SAE Media Group":MAILTO:richard.jones@saemediagroup.com
END:VEVENT
END:VCALENDAR